Labcorp Holdings (LH) Q1 2024 Earnings
Labcorp Holdings reported Q1 2024 revenue of $3.2B, beat analyst consensus of $3.1B by $58.5M. Diluted EPS came in at $3.68, beat the $3.48 consensus by $0.20. Labcorp Holdings reports across 2 business segments, led by Diagnostics Laboratories (Dx) and Biopharma Laboratory Services (BLS).
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Labcorp Holdings's Q1 2024 earnings report.
Labcorp Holdings (LH) reported Q1 2024 earnings on April 25, 2024 before market open.
Labcorp Holdings reported revenue of $3.2B and diluted EPS of $3.68 for Q1 2024.
Revenue beat the consensus estimate of $3.1B by $58.5M. EPS beat the consensus estimate of $3.48 by $0.20.
You can read the 10-Q periodic report (0000920148-24-000032) directly on SEC EDGAR. The filing index links above go to sec.gov.